Cybin (HELP) Income from Non-Controlling Interests (2020 - 2024)

Cybin (HELP) posted quarterly Income from Non-Controlling Interests of $715.85 for Q4 2024, down 67.45% on a QoQ basis from $2199.2 in Q3 2024.

Cybin (HELP) Income from Non-Controlling Interests (2020 - 2024) Analysis & Trends

Cybin (HELP) has reported Income from Non-Controlling Interests for 4 consecutive years, with $715.85 the latest figure, recorded in Q4 2024.

  • Quarterly Income from Non-Controlling Interests changed N/A year-over-year to $715.85 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was -$1.7 million (changed N/A YoY) and the FY2021 annual result came in at $53757.5, changed N/A from the prior year.
  • Income from Non-Controlling Interests fell to $715.85 in Q4 2024 per HELP's latest filing, from $2199.2 in the prior quarter.
  • Over the last five years, Income from Non-Controlling Interests for HELP reached as high as $25219.3 in Q2 2021 and fell as low as -$1.7 million in Q3 2022.
  • A 4-year average of -$254386.7 and a median of $1442.4 in 2020 frame the typical range for Income from Non-Controlling Interests.
  • Annual changes were most pronounced in 2021 — Income from Non-Controlling Interests jumped 1648.42% — and 2022, when it tumbled 1000.81%.
  • Year by year, Income from Non-Controlling Interests stood at $1442.4 in 2020, then plunged by 10564.29% to -$150937.8 in 2021, then slumped by 1000.81% to -$1.7 million in 2022, then surged by 100.04% to $715.85 in 2024.
  • According to Business Quant data, Income from Non-Controlling Interests over the past three periods registered $715.85, $2199.2, and $2193.4 for Q4 2024, Q3 2024, and Q2 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inc. Minority (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Cybin 28.04 Mn 28.04 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2024 715.85
Sep 30, 2024 2,199.16
Jun 30, 2024 2,193.42
Sep 30, 2022 -1.66 Mn
Sep 30, 2021 -150,937.77
Jun 30, 2021 25,219.34
Jun 30, 2020 1,442.41